Literature DB >> 9406655

Structure and function of uridine diphosphate glucuronosyltransferases.

R Meech1, P I Mackenzie.   

Abstract

1. The uridine diphosphate (UDP)-glucuronosyltransferases (UGT) are a family of enzymes that catalyse the covalent addition of glucuronic acid to a wide range of lipophilic chemicals. They play a major role in the detoxification of many exogenous and endogenous compounds by generating products that are more polar and, thus, more readily excreted in bile or urine. 2. Inherited deficiencies in UGT forms are deleterious, as exemplified by the debilitating effects of hyperbilirubinaemia and neurotoxicity in subjects with mutations in the enzyme that converts bilirubin to its more polar glucuronide. 3. The UGT protein can be conceptually divided into two domains with the amino-terminal half of the protein demonstrating greater sequence divergence between isoforms. This region apparently determines aglycone specificity. The aglycone binding site is presumed to be a 'loose' fit, as many structurally diverse substrates can be bound by the same UGT isoform. The carboxyl-terminal half, which is more conserved in sequence between different isoforms, is believed to contain a binding site for the cosubstrate UDP glucuronic acid (UDPGA). 4. Uridine diphosphate glucuronosyltransferase is localized to the endoplasmic reticulum (ER) and spans the membrane with a type I topology. The putative transmembrane domain is located near the carboxyl terminus of the protein such that only a small portion of the protein resides in the cytosol. This cytosolic tail is believed to contain an ER-targeting signal. The major portion of the protein is located in the ER lumen, including the proposed substrate-binding domains and the catalytic site. 5. The microsomal membrane impedes the access of UDPGA to the active site, resulting in latency of UGT activity in intact ER-derived microsomes. Active transport of UDPGA is believed to occur in hepatocytes, but the transport system has not been fully characterized. Uridine diphosphate glucuronosyltransferase activity is also highly lipid dependent and the enzyme may contain regions of membrane association in addition to the transmembrane domain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406655     DOI: 10.1111/j.1440-1681.1997.tb02718.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  38 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 2.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

3.  Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment.

Authors:  Marzia Del Re; Tiziana Latiano; Leonardo Fidilio; Giuliana Restante; Franco Morelli; Evaristo Maiello; Romano Danesi
Journal:  EPMA J       Date:  2017-03-07       Impact factor: 6.543

4.  Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines.

Authors:  Centdrika R Dates; Tariq Fahmi; Sebastian J Pyrek; Aiwei Yao-Borengasser; Barbara Borowa-Mazgaj; Stacie M Bratton; Susan A Kadlubar; Peter I Mackenzie; Randy S Haun; Anna Radominska-Pandya
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes.

Authors:  Robyn Meech; Anne Rogers; Lizhe Zhuang; Benjamin C Lewis; John O Miners; Peter I Mackenzie
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

6.  Photoaffinity labeling probe for the substrate binding site of human phenol sulfotransferase (SULT1A1): 7-azido-4-methylcoumarin.

Authors:  G Chen; E Battaglia; C Senay; C N Falany; A Radominska-Pandya
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

7.  Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).

Authors:  Siddhartha S Ghosh; Yang Lu; Sung W Lee; Xia Wang; Chandan Guha; Jayanta Roy-Chowdhury; Namita Roy-Chowdhury
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

Review 8.  5,6-dimethylxanthenone-4-acetic acid (DMXAA): a new biological response modifier for cancer therapy.

Authors:  Shufeng Zhou; Philip Kestell; Bruce C Baguley; James W Paxton
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

9.  Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase.

Authors:  Peter I Mackenzie; Anne Rogers; Joanna Treloar; Bo R Jorgensen; John O Miners; Robyn Meech
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

Review 10.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.